Particularly Aβ1-42, which exhibits strong neurotoxic properties, was identified in amyloid aggregates in AD brains, which led to the assumption that BACE1 is the major β-secretase and one of the most promising targets for therapeutic interventions [16–18]. This evidence concerns the gene BACE1 and Alzheimer disease.